Skip to main content
Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals-H-C-1051-II-01

Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals-H-C-1051-II-01

43 views
Download
Pharmaceutical

Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals-H-C-1051-II-01

Advanced pharmaceutical formulation for targeted therapeutic intervention.

Dosage

Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals-H-C-1051-II-01

Strength

Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals-H-C-1051-II-01

Pack Size

Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals-H-C-1051-II-01

Form

Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals-H-C-1051-II-01

Source

European Medicines Agency

View Source

Safety Profile

Contraindications

Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals-H-C-1051-II-01

Side Effects

Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals-H-C-1051-II-01

Related Clinical Articles

Scan this QR code to access this page quickly on your mobile device.

QR Code